Aventiq Bio - Mitigate Risk. Accelerate Success.

Medical Devices & Combination Products

Medical device innovation requires more than a manufacturer-it requires a lifecycle guardian. Outsourcing to emerging markets often results in "Regulatory Debt": incomplete Design History Files (DHF), inconsistent large animal data, and biocompatibility failures that trigger FDA holds.

Aventiq Bio acts as your Regulatory Shield in India. We provide on-ground technical oversight to ensure every milestone-from initial prototyping to large animal performance studies-is "Submission-Ready" the first time. We reduce your Total Cost of Ownership (TCO) while accelerating global market access.

Independent governance for R&D Design (DHF), Large Animal Preclinical Safety, and Biocompatibility. We bridge the gap between India’s cost-effective MedTech ecosystem and stringent FDA/MDR/CDSCO requirements.

The Aventiq MedTech Framework

Design Integrity & DHF Governance

DHF Remediation: On-ground oversight of Design History Files to ensure absolute traceability between User Needs and Design Verification.
ISO 14971 Risk Management: Independent auditing of Risk Management Files (FMEA/FTA) to ensure patient safety is integrated into the device architecture.
Usability Engineering: Oversight of Formative and Summative Human Factors studies to meet evolving FDA and MDR usability expectations.

Preclinical & Biological Safety

Large Animal Oversight: Strategic management of Porcine, Canine, and Ovine model studies for safety and performance testing (GLP-compliant).
ISO 10993 Biocompatibility: Specialized governance of chemical characterization and biological risk assessments to prevent unexpected toxicological failures.
Sterilization Validation: Technical audits of ETO, Gamma, and Steam sterilization cycles and primary packaging integrity (ISO 11607).

Combination Products & Quality Ops

The Hybrid Bridge: Managing the complex regulatory intersection of drug-delivery systems (pre-filled syringes, drug-eluting stents, and patches).
ISO 13485 Quality Guard: Turnkey QMS implementation and "Mock Audits" to prepare Indian partners for FDA and Notified Body inspections.
PMCF & Clinical Data: Independent oversight of Post-Market Clinical Follow-up (PMCF) and ISO 14155 clinical investigations for Class III devices.

Medical Devices & Combination Products

Medical Devices & Combination Products

The Aventiq MedTech Framework

Design Integrity & DHF Governance

DHF Remediation: On-ground oversight of Design History Files to ensure absolute traceability between User Needs and Design Verification.

ISO 14971 Risk Management: Independent auditing of Risk Management Files (FMEA/FTA) to ensure patient safety is integrated into the device architecture.

Usability Engineering: Oversight of Formative and Summative Human Factors studies to meet evolving FDA and MDR usability expectations.

Preclinical & Biological Safety

Large Animal Oversight: Strategic management of Porcine, Canine, and Ovine model studies for safety and performance testing (GLP-compliant).

ISO 10993 Biocompatibility: Specialized governance of chemical characterization and biological risk assessments to prevent unexpected toxicological failures.

Sterilization Validation: Technical audits of ETO, Gamma, and Steam sterilization cycles and primary packaging integrity (ISO 11607).

Combination Products & Quality Ops

The Hybrid Bridge: Managing the complex regulatory intersection of drug-delivery systems (pre-filled syringes, drug-eluting stents, and patches).

ISO 13485 Quality Guard: Turnkey QMS implementation and "Mock Audits" to prepare Indian partners for FDA and Notified Body inspections.

PMCF & Clinical Data: Independent oversight of Post-Market Clinical Follow-up (PMCF) and ISO 14155 clinical investigations for Class III devices.

All engagements are confidential. No information is shared without written consent.